ORIGINAL ARTICLE


Open Access Peer-Reviewed

5831

Views

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression

Vol.37 Issue 1/2015:


Message

 


© 2026 All rights reserved